We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+6.36%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$6.76B
AUM Growth
-$342M
(-4.8%)
Cap. Flow
-$367M
Cap. Flow
% of AUM
-5.43%
Top 10 Holdings %
Top 10 Hldgs %
43.88%
Holding
93
New
7
Increased
14
Reduced
55
Closed
7
Top Buys
| 1 |
VERV
Verve Therapeutics
VERV
|
+$80.4M |
| 2 |
ZY
Zymergen Inc. Common Stock
ZY
|
+$60.1M |
| 3 |
SkinHealth Systems
SKIN
|
+$59.8M |
| 4 |
ONEM
1Life Healthcare
ONEM
|
+$41.7M |
| 5 |
Lifestance Health
LFST
|
+$33.2M |
Top Sells
| 1 |
Medtronic
MDT
|
+$116M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
+$96.2M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
+$85.8M |
| 4 |
Biogen
BIIB
|
+$45.6M |
| 5 |
Beam Therapeutics
BEAM
|
+$38.2M |
Sector Composition
| 1 | Healthcare | 95.41% |
| 2 | Consumer Staples | 1.58% |
| 3 | Financials | 0.69% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nurix Therapeutics
NRIX
$2.48B
| $84.6M | 1.25% |
3,190,077
-124,040
| -4% | -$3.64M |
|
27
Regenxbio
RGNX
$634M
| $83.1M | 1.23% |
2,138,201
-202,112
| -9% | -$7.23M |
|
28
Stoke Therapeutics
STOK
$1.86B
| $82.8M | 1.22% |
2,458,558
-85,504
| -3% | -$3.02M |
|
|
RPTX
29
DELISTED
Repare Therapeutics
RPTX
| $81.8M | 1.21% |
2,624,396
-41,100
| -2% | -$1.35M |
|
30
Annexon
ANNX
$1.06B
| $77.1M | 1.14% |
3,425,038
-33,792
| -1% | -$749K |
|
|
EPZM
31
DELISTED
Epizyme, Inc
EPZM
| $70.8M | 1.05% |
8,515,060
-309,306
| -4% | -$2.61M |
|
|
AKRO
32
DELISTED
Akero Therapeutics
AKRO
| $69.6M | 1.03% |
2,804,944
+291,198
| +12% | +$8.18M |
|
33
Scholar Rock
SRRK
$6.48B
| $66.7M | 0.99% |
2,307,028
+130,400
| +6% | +$3.99M |
|
34
Prothena Corp
PRTA
$441M
| $62.5M | 0.92% |
1,215,657
-641,415
| -35% | -$20M |
|
|
ZY
35
DELISTED
Zymergen Inc. Common Stock
ZY
| $60.9M | 0.9% |
+1,522,900
| New | +$60.1M |
|
|
IMGN
36
DELISTED
Immunogen Inc
IMGN
| $58.5M | 0.87% |
8,880,945
-807,121
| -8% | -$5.63M |
|
|
ONEM
37
DELISTED
1Life Healthcare
ONEM
| $55.1M | 0.82% |
1,666,963
+1,104,649
| +196% | +$41.7M |
|
|
NGM
38
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $55.1M | 0.81% |
2,792,448
+40,633
| +1% | +$951K |
|
|
TCRR
39
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $53.1M | 0.79% |
3,235,809
-374,979
| -10% | -$7.57M |
|
40
Genmab
GMAB
$17.9B
| $50.1M | 0.74% |
1,227,588
-104,624
| -8% | -$4.04M |
|
41
ALX Oncology
ALXO
$273M
| $50M | 0.74% |
914,035
-64,565
| -7% | -$3.86M |
|
42
SelectQuote
SLQT
$132M
| $46.5M | 0.69% |
2,411,957
+406,903
| +20% | +$10.2M |
|
43
ICU Medical
ICUI
$3.95B
| $45.9M | 0.68% |
222,929
-1,225
| -0.5% | -$252K |
|
44
Nuvation Bio
NUVB
$2.05B
| $42.3M | 0.63% |
4,541,009
| – | – |
|
45
Elevance Health
ELV
$84.8B
| $41.5M | 0.61% |
108,801
-21,604
| -17% | -$8.26M |
|
46
Charles River Laboratories
CRL
$11B
| $40.1M | 0.59% |
108,374
-58,305
| -35% | -$19.5M |
|
47
Cigna
CI
$78.8B
| $37.9M | 0.56% |
159,727
-120,330
| -43% | -$30.1M |
|
48
UnitedHealth
UNH
$380B
| $37.8M | 0.56% |
94,465
-19,911
| -17% | -$7.94M |
|
49
Neurogene
NGNE
$787M
| $36.2M | 0.54% |
195,962
-9,916
| -5% | -$2.19M |
|
|
50
Lifestance Health
LFST
$4.19B
| $35M | 0.52% |
+1,257,067
| New | +$33.2M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO